ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
62 701,83
-0,30%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Mersana Therapeutics Inc (MRSN)

  7. Mersana Therapeutics Inc (MRSN) Actualités

MRSN Mersana Therapeutics Inc

3,46
0,10 (2,98%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Mersana Therapeutics Inc MRSN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,10 2,98% 3,46 01:39:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,52 3,42 3,63 3,46 3,36
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/5/202422:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
02/5/202414:00GLOBEMersana Therapeutics to Host First Quarter 2024 Conference..
04/4/202422:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
28/2/202422:08EDGAR2Form 8-K - Current report
28/2/202422:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202422:05EDGAR2Form POS AM - Post-Effective amendments for registration..
28/2/202414:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202414:43EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
28/2/202413:07EDGAR2Form 8-K - Current report
28/2/202413:00GLOBEMersana Therapeutics Provides Business Update and..
27/2/202414:01GLOBEMersana Therapeutics to Present at Upcoming Investor..
21/2/202414:00GLOBEMersana Therapeutics to Host Fourth Quarter and Year End..
16/2/202422:30EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15/2/202402:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:43EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202414:00GLOBEMersana Therapeutics to Participate in Guggenheim’s 6th..
17/1/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202403:14EDGAR2Form 144 - Report of proposed sale of securities
17/1/202403:13EDGAR2Form 144 - Report of proposed sale of securities
17/1/202403:13EDGAR2Form 144 - Report of proposed sale of securities
12/1/202422:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/1/202414:06EDGAR2Form 8-K - Current report
05/1/202414:01GLOBEMersana Therapeutics Announces Business Updates, Expected..
04/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:11EDGAR2Form 8-K - Current report
01/12/202322:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
07/11/202314:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:18EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEMersana Therapeutics Provides Business Update and Announces..
31/10/202321:30GLOBEMersana Therapeutics to Host Third Quarter 2023 Conference..
31/10/202317:59DJNMersana Therapeutics Shares Rise 8% After FDA Lifts Clinical..
31/10/202314:07DJNMersana Says FDA Lifts Clinical Hold on Gastric-Cancer..
31/10/202313:12EDGAR2Form 8-K - Current report
31/10/202313:00GLOBEMersana Therapeutics Announces FDA has Lifted Clinical Hold..
27/10/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202314:27EDGAR2Form 8-K - Current report
07/9/202323:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202323:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
MRSN
Mersana Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés